You have 9 free searches left this month | for more free features.

Norelgestromin

Showing 1 - 25 of 45

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Contraception Trial in Berlin (MR-130A-01 Transdermal patch)

Recruiting
  • Contraception
  • MR-130A-01 Transdermal patch
  • Berlin, Germany
    dinox GmbH
Sep 15, 2023

Contraception Trial in United States (MR-100A-01)

Recruiting
  • Contraception
  • Mobile, Alabama
  • +54 more
Nov 10, 2022

Contraception Trial (Levonorgestrel (LNG)/Ethinylestradiol (EE) oral contraceptive tablets, norelgestrominum and

Completed
  • Contraception
  • Levonorgestrel (LNG)/Ethinylestradiol (EE) oral contraceptive tablets
  • +2 more
  • (no location specified)
Feb 2, 2022

Healthy Trial in Dallas (Tirzepatide, EE/NGM)

Completed
  • Healthy
  • Dallas, Texas
    Covance Dallas
Feb 17, 2021

HCV Infection Trial in Christchurch (SOF/VEL/VOX, VOX, Norgestimate/ethinyl estradiol)

Completed
  • HCV Infection
  • Christchurch, New Zealand
    (unnamed)
Aug 17, 2020

Healthy Trial in Antwerpen, Berlin, Groningen (EVRA patch (NGMN+EE) (Treatment A) (Reference), High molecular weight

Completed
  • Healthy
  • EVRA patch (NGMN+EE) (Treatment A) (Reference)
  • High molecular weight polyisobutylene (HMW PIB) patch (NGMN+EE) (Treatment B) (Test)
  • Antwerpen, Belgium
  • +2 more
Feb 6, 2020

Healthy Trial in Merksem (EVRA patch (NGMN+EE) (Treatment A) (Reference), HMW PIB patch (NGMN+EE) (Treatment B) (Test))

Completed
  • Healthy
  • EVRA patch (NGMN+EE) (Treatment A) (Reference)
  • HMW PIB patch (NGMN+EE) (Treatment B) (Test)
  • Merksem, Belgium
    Clinical Pharmacology Unit
May 7, 2019

Bone; Disorder, Development and Growth Trial in University Park (Combined Oral Contraceptive, Transdermal Contraceptive,

Completed
  • Bone; Disorder, Development and Growth
  • Combined Oral Contraceptive
  • +2 more
  • University Park, Pennsylvania
    Women's Health and Exercise Laboratories, The Pennsylvania State
Feb 21, 2020

Headache, Migraine Trial in United States (Erenumab, Ethynil Estradiol/Norgestimate Oral Contraceptive)

Completed
  • Headache, Migraine
  • Erenumab
  • Ethynil Estradiol/Norgestimate Oral Contraceptive
  • Anaheim, California
  • +3 more
Jun 6, 2018

Healthy Volunteers Trial in Dallas (Ortho-Cyclen, Evacetrapib)

Completed
  • Healthy Volunteers
  • Dallas, Texas
    For additional information regarding investigative sites for thi
Feb 18, 2018

Depressive Disorder, Major Trial in Madison (LY2216684, Ortho Cyclen, Placebo)

Completed
  • Depressive Disorder, Major
  • Madison, Wisconsin
    For additional information regarding investigative sites for thi
Mar 26, 2018

Infection, Human Immunodeficiency Virus Trial (BMS-955176, Ortho Cyclen)

Completed
  • Infection, Human Immunodeficiency Virus
  • (no location specified)
Apr 13, 2018

Non-fatal Venous Thromboembolism, Ischemic Stroke and Myocardial

Completed
  • Contraception
  • +2 more
    • (no location specified)
    Jul 15, 2016

    ORTHO EVRA in Relation to Venous Thromboembolism, Stroke and

    Completed
    • Contraception
    • Female Contraception
    • Monophasic or triphasic Oral contraceptive tablet
    • Ortho Evra transdermal patch containing 6 mg NGMN/0.75 mg EE
    • (no location specified)
    Jul 15, 2016

    Venous Thromboembolism, Myocardial Infarction, and Stroke Among

    Completed
    • Contraception
    • Female Contraception
    • Transdermal Contraceptive System
    • Norgestimate-containing oral contraceptives with EE
    • (no location specified)
    Jul 15, 2016

    Pharmacokinetics Trial in Boston (Xulane Contraceptive Patch)

    Completed
    • Pharmacokinetics
    • Xulane Contraceptive Patch
    • Boston, Massachusetts
      Boston Medical Center
    Apr 17, 2017

    Contraception Trial in Worldwide (BAY86-5016, SH P00331F, SH P00331N)

    Completed
    • Contraception
    • BAY86-5016, SH P00331F
    • SH P00331N
    • Wörgl, Tirol, Austria
    • +27 more
    Dec 30, 2015

    Chronic Hepatitis C Trial in Tempe, Austin, St. Laurent (BMS-790052, Ortho Tri-Cyclen®)

    Completed
    • Chronic Hepatitis C
    • Tempe, Arizona
    • +2 more
    Sep 16, 2015

    Contraception Trial in Austria, Czech Republic, Netherlands (Ethinylestradiol/Gestodene (FC Patch Low BAY86-5016),

    Completed
    • Contraception
    • Ethinylestradiol/Gestodene (FC Patch Low BAY86-5016)
    • Norelgestromin/Ethinylestradiol (EVRA)
    • Mödling, Niederösterreich, Austria
    • +22 more
    Apr 1, 2014

    Healthy Trial in Groningen (Norgestimate /Ethinyl estradiol tablets (NGM/EE) (Wet Process), Norgestimate /Ethinyl estradiol

    Completed
    • Healthy
    • Norgestimate /Ethinyl estradiol tablets (NGM/EE) (Wet Process)
    • Norgestimate /Ethinyl estradiol tablets (NGM/EE) (Dry Process)
    • Groningen, Netherlands
      (unnamed)
    Oct 2, 2014

    Diabetes, Type 2 Trial in Dallas (Ortho-Cyclen, Dulaglutide)

    Completed
    • Diabetes Mellitus, Type 2
    • Dallas, Texas
      For additional information regarding investigative sites for thi
    Oct 3, 2014

    Contraception Trial in Brazil, Mexico (Norelgestromine (NLGM)/ethinyl estradiol (EE))

    Completed
    • Contraception
    • Norelgestromine (NLGM)/ethinyl estradiol (EE)
    • Belo Horizonte, Brazil
    • +11 more
    May 14, 2014

    Cachexia Trial in Hershey (transdermal Megace)

    Withdrawn
    • Cachexia
    • transdermal Megace
    • Hershey, Pennsylvania
      Hershey Medical Center
    Oct 24, 2013

    Healthy Volunteers Trial in Neptune (Treatment A: ORTHO EVRA patch (NGMN + EE) with an adhesive overlay, Treatment B: ORTHO EVRA

    Completed
    • Healthy Volunteers
    • Treatment A: ORTHO EVRA patch (NGMN + EE) with an adhesive overlay
    • Treatment B: ORTHO EVRA patch (NGMN + EE) without an overlay
    • Neptune, New Jersey
      (unnamed)
    Mar 19, 2013

    Contraception, Female Contraception Trial (EVRA transdermal contraceptive patch 6 mg NGMN and 0.75 mg EE)

    Completed
    • Contraception
    • Female Contraception
    • EVRA transdermal contraceptive patch 6 mg NGMN and 0.75 mg EE
    • (no location specified)
    Dec 11, 2012